BTG plc (LON:BTG – Get Free Report) shares crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 840 ($10.99) and traded as high as GBX 840 ($10.99). BTG shares last traded at GBX 840 ($10.99), with a volume of 271,742 shares trading hands.
BTG Stock Up 0.1 %
The firm has a market capitalization of £3.26 billion and a price-to-earnings ratio of 29.47. The stock’s 50 day moving average price is GBX 840 and its two-hundred day moving average price is GBX 840.
BTG Company Profile
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.
Featured Stories
- Five stocks we like better than BTG
- The 3 Best Fintech Stocks to Buy Now
- NVIDIA’s AI Dominance: Why Analysts Predict Major Upside Ahead
- How to Calculate Inflation Rate
- These Stocks Are Using Buybacks to Unlock Big Gains for Investors
- The Role Economic Reports Play in a Successful Investment Strategy
- This Is the Entry Into PepsiCo You’ve Been Waiting For
Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.
